FDA Adverse Event Injury Summary report: N

ACL TOP 550 CTS

MDR report key: 8383931 · Received March 1, 2019

Report

Report Number
1217183-2019-00003
Event Type
Injury
Date Received
March 1, 2019
Date of Event
February 9, 2019
Report Date
March 1, 2019
Manufacturer
INSTRUMENTATION LABORATORY
Product Code
GKP
UDI-DI
08426950729242
PMA / PMN Number
K150877
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AN INVESTIGATION WAS CONDUCTED THAT INCLUDED REVIEW OF THE INSTRUMENT APTT CLOT CURVES ALONG WITH THE VERIFICATION OF SAMPLE AND REAGENT FLUIDIC PRECISION. APTT QUALITY CONTROL WAS WITHIN PASSING CRITERIA PRIOR TO PATIENT TESTING AND IMMEDIATELY AFTER THE QUESTIONABLE RESULTS WERE GENERATED. THE CONCLUSION IS THAT THE ACL TOP 550 CTS WAS PERFORMING AS INTENDED. BASED ON THE ABOVE, THERE WAS NO INDICATION OF AN INSTRUMENT MALFUNCTION AND NO REMEDIAL ACTION IS NEEDED.

Description of Event or Problem · 1

A CUSTOMER REPORTED THAT THEIR ACL TOP 550 CTS GENERATED ERRONEOUS APTT RESULTS USING HEMOSIL SYNTHASIL. THREE PATIENTS WERE ADMINISTERED AN INCREASED DOSE OF HEPARIN BASED ON THE ERRONEOUS APTT RESULTS. THE APTT RESULTS WERE LATER CORRECTED AND THE HEPARIN DOSES WERE ADJUSTED AS APPROPRIATE. AFTER THE ADDITIONAL DOSE OF HEPARIN, THE PATIENTS WERE MONITORED AND THERE WERE NO COMPLICATIONS FROM THE ADDITIONAL HEPARIN ADMINISTERED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
174915 ACL TOP 550 CTS INSTRUMENT, COAGULATION, AUTOMATED GKP INSTRUMENTATION LABORATORY 2800-45 08426950729242

Patients

Seq Age Sex Outcome Treatment
1 Other